Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases
2016
Lo Van, Amanda | Sakayori, Nobuyuki | Hachem, Mayssa | Belkouch, Mounir | Picq, Madeleine | Lagarde, Michel | Osumi, Noriko | Bernoud-Hubac, Nathalie | Cardiovasculaire, métabolisme, diabétologie et nutrition | Institut National de la Recherche Agronomique -Université Claude Bernard Lyon | Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon | Université de Lyon-Institut National des Sciences Appliquées -Institut National des Sciences Appliquées -Hospices Civils de Lyon -Institut National de la Santé et de la Recherche Médicale | Graduate School of Medicine, Neuroscience Center, Developmental Neuroscience | Tohoku University | National Institute of Applied Sciences-Lyon | National Institute for Health and Medical Research
Docosahexaenoic acid (DHA; 22:6 omega-3) is highly enriched in the brain and is required for proper brain development and function. Its deficiency has been shown to be linked with the emergence of neurological diseases. Dietary omega-3 fatty acid supplements including DHA have been suggested to improve neuronal development and enhance cognitive functions. However, mechanisms of DHA incorporation in the brain remain to be fully understood. Findings suggested that DHA is better incorporated when esterified within lysophospholipid rather than under its non-esterified form. Furthermore, DHA has the potential to be converted into diverse oxylipins with potential neuroprotective effects. Since DHA is poorly synthesized de novo, targeting the brain with specific carriers of DHA might provide novel therapeutic approaches to neurodegenerative diseases.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by National Institute for Agricultural Research